Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

Historical Holders from Q1 2025 to Q3 2025

Symbol
KPTI on Nasdaq
CUSIP
48576U205
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
13.3M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
2.95M
Holdings value
$19.3M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
49
Number of buys
14
Number of sells
-23
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 13.8% +67.5% $15.1M $10.3M 2.3M +216% T. Rowe Price Investment Management, Inc. Oct 31, 2025
Opaleye Management Inc. 9.48% $10.3M 1.57M Opaleye Management Inc. Oct 10, 2025
J. WOOD CAPITAL ADVISORS LLC 4.99% $6.55M 1M J. Wood Capital Advisors LLC Oct 14, 2025
Affinity Asset Advisors, LLC 7.83% $2.85M 664K Affinity Healthcare Fund, LP Apr 3, 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 4.9% $4.25M 650K HIGHBRIDGE CAPITAL MANAGEMENT, LLC Sep 30, 2025
JPMORGAN CHASE & CO 4.9% -6% $2.8M -$149K 428K -5.06% JPMORGAN CHASE & CO. Sep 30, 2025
VANGUARD GROUP INC 4.7% $2.67M 408K The Vanguard Group Sep 30, 2025

Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2.95M $19.3M -$7.68M $6.54 49
2025 Q2 4.38M $18.9M +$4.72M $4.31 49
2025 Q1 3.31M $12.4M +$12.3M $3.74 46